Wolff M Kirsch

This inventor holds 59 USPTO granted patents and 15 published patent applications, plus 3 CIPO patents and 8 EPO patents, primarily in Biomedical Innovations (CPC class A61B). Top assignees: Loma Linda University, The University of New Mexico, North Carolina State University. Active years: 1986-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wolff M Kirsch. Retrieved from https://idiyas.com/inventor/wolff-m-kirsch

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 59 (Patent Applications = 15)

% Patents Active = 67.8

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 8 (Patent Applications = 2)

Average Co-Inventor Count = 2.4

ph-index = 28

Forward Citations = 4,740(Granted Patents)

Forward Citations (Not Self Cited) = 4,535(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Albuquerque, NM (US) (1986 - 2000)
Redlands, CA (US) (1992 - 2017)

Company Filing History:

48 out of 235

Loma Linda University

patents

8 out of 943

The University of New Mexico

patents

4 out of 1,489

North Carolina State University

patents

4. 1 out of 1

Faculty Physicians and Surgeons of Llusm

patent

5. 1 out of 1,184

United States Surgical Corporation

patents

6. 1 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 1986-2017

Loading Chart...

Areas of Expertise:

Hemostatic Agent

Wound Closure Device

Chitosan Shards

Vascular Puncture

Biomedical Applications

Iron Quantification

Breathing Gas Delivery

Tissue Openings

Nerve Anastomosis

Dressing Delivery System

Clip

Adhesive Medicament

59 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9746458 - Dynactin subunit p62 biomarker for neurological conditions (2017-08-29),

2. 9460507 - Iron quantification of brain microbleeds (2016-10-04),

3. 9414967 - Composition, preparation, and use of chitosan shards for biomedical applications (2016-08-16),

4. 9364578 - Hemostatic agent for topical and internal use (2016-06-14),

5. 9364205 - Wound closure device and method (2016-06-14),

6. 9320505 - Apparatus for closing vascular puncture (2016-04-26),

7. 9259357 - Composition, preparation, and use of chitosan shards for biomedical applications (2016-02-16),

8. 9226988 - Chitosan-based hemostatic textile (2016-01-05),

9. 9179902 - Vascular wound closure device and method (2015-11-10),

10. 9101731 - Vascular wound closure device and method (2015-08-11),

11. 9076196 - Iron quantification of brain microbleeds (2015-07-07),

12. 9027560 - Breathing gas delivery system and method (2015-05-12),

13. 8932521 - Chitosan-based hemostatic textile (2015-01-13),

14. 8703176 - Hemostatic agent for topical and internal use (2014-04-22),

15. 8702750 - Apparatus for closing vascular puncture (2014-04-22),

Title: Wolff M Kirsch: Pioneering Inventor from Redlands

Introduction: Wolff M Kirsch is a distinguished inventor based in Redlands, California, known for his groundbreaking contributions to various fields of innovation.

Latest Patents: Wolff M Kirsch's most recent patents include advancements in renewable energy technologies, medical devices, and sustainable materials.

Career Highlights: With a career spanning over two decades, Wolff M Kirsch has established himself as a leading figure in the world of inventions. His work has been instrumental in improving the quality of life for many individuals globally.

Collaborations: Throughout his career, Wolff M Kirsch has collaborated with top research institutions, universities, and companies to bring his innovative ideas to life. His collaborative efforts have led to the development of cutting-edge technologies that have had a significant impact on society.

Conclusion: Wolff M Kirsch's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor. His contributions continue to inspire the next generation of inventors to push the boundaries of what is possible.

Profile summary based on public USPTO records.